Vulvodynia
66
10
12
35
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
11 trials with published results (17%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.1%
8 terminated out of 66 trials
81.4%
-5.1% vs benchmark
11%
7 trials in Phase 3/4
31%
11 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 35 completed trials
Clinical Trials (66)
Biomodulation and Rehabilitation Interventions to tarGet Pelvic Health
Effectiveness of a Four-Session Focal Shock Wave Therapy Protocol in Women With Vulvodynia
Topical Ketotifen 0.25% for Secondary Vestibulodynia
A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia)
Prospective Data Bank Creation to Study Vaginal Conditions
Multidisciplinary Treatment of Chronic Vulvar Pain
Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial
Young Vulvodynia: Effect and Efficacy of Multimodal Treatment.
Vulvodynia Pain Thresholds
Vaginal Ecosystem and Network in the United States Study
Effect of Acupuncture on Patient Vulvodynia Outcomes
Therapeutic Efficacy of Erbium:YAG Laser in Postpartum Patients With Episiotomy Scars
Vestibulodynia At High Resolution: Omics Approach to Improve Diagnosis
Analysis of the Understanding of the French Version of the Vulvar Pain Assessment Questionnaire
Lasertherapy for Vulvodynia
Efficacy of High Intensity Laser for Provoked Vestibulodynia
Acupuncture in a Multidisciplinary Approach for Vulvodynia and Chronic Pelvic Pain
Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia
Vestibulectomy Surgical Techniques Comparison Study
Light Emitting Diode in the Treatment of Vulvodynia